Management of the vaccination campaign in a population of frail older outpatients affected by cognitive or endocrinological conditions: a pilot study in Italy.

Nicola Veronese, Francesco Saverio Ragusa, Pascal Roberto Titone, Laura Vernuccio, Giuseppina Catanese, Maria Angela Randazzo, Mario Palermo, Giovanna Di Bella, Pasquale Mansueto, Ligia J Dominguez, Mario Barbagallo
Author Information
  1. Nicola Veronese: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy. nicola.veronese@unipa.it.
  2. Francesco Saverio Ragusa: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.
  3. Pascal Roberto Titone: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.
  4. Laura Vernuccio: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.
  5. Giuseppina Catanese: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.
  6. Maria Angela Randazzo: Prevention and Epidemiology Unit, Palermo Local Health Authority, Palermo, Italy.
  7. Mario Palermo: Sicilian Health Department, Public Health and Environmental Risks Service, Palermo, Italy.
  8. Giovanna Di Bella: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.
  9. Pasquale Mansueto: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.
  10. Ligia J Dominguez: Department of Medicine and Surgery, "Kore" University of Enna, Enna, Italy.
  11. Mario Barbagallo: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Geriatrics Section, University of Palermo, Palermo, Italy.

Abstract

Vaccination, particularly against pneumococcus and influenza, is a low-cost primary prevention, useful to avoid hard complications, particularly among frail older people. In this pilot study, we aimed to assess the effect of a strategy for influenza and pneumococcal vaccination for outpatients mainly affected by cognitive or endocrinological conditions, evaluating what could stimulate or demotivate vaccination among older people. This study was conducted during the 2023-2024 influenza season at the outpatient clinics in Palermo, Italy. A total 76 patients were included. More than half of the patients could be considered as pre-frail and about 20% frail, according to a comprehensive geriatric evaluation. Among patients, 46.05% received only vaccination against pneumococcus, 28.95% both vaccinations, and 25.0% only against influenza. Compared with the previous seasons, a 19.5% increase of influenza and 90.2% of pneumococcal vaccine uptake was observed. Side effects of vaccination were the main reason of the previous rejection, namely 76.9% for influenza and 53.8% for anti-pneumococcal vaccination. In conclusion, our study indicates how a new vaccination strategy in different settings could be feasible. Proposing influenza and pneumococcal vaccination for frail older outpatients could be an effective instrument to improve immunization coverage that is still low among older people.

Keywords

References

  1. J Clin Med. 2023 Sep 18;12(18): [PMID: 37762966]
  2. Hum Vaccin Immunother. 2016 Dec;12(12):3056-3064 [PMID: 27629584]
  3. MMWR Recomm Rep. 2022 Aug 26;71(1):1-28 [PMID: 36006864]
  4. EBioMedicine. 2015 Jun 23;2(8):891-7 [PMID: 26425696]
  5. Vaccines (Basel). 2023 Jul 10;11(7): [PMID: 37515039]
  6. Am J Med. 1991 Dec;91(6):584-8 [PMID: 1750427]
  7. Ageing Res Rev. 2022 Jan;73:101534 [PMID: 34861456]
  8. Open Forum Infect Dis. 2015 Oct 01;2(4):ofv119 [PMID: 26430697]
  9. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3 [PMID: 33684019]
  10. Vaccines (Basel). 2024 Mar 12;12(3): [PMID: 38543931]
  11. Hum Vaccin Immunother. 2022 Nov 30;18(6):2133912 [PMID: 36269145]
  12. Cochrane Database Syst Rev. 2018 May 30;5:CD005188 [PMID: 29845606]
  13. JAMA. 2000 Oct 11;284(14):1820-7 [PMID: 11025835]
  14. PLoS One. 2019 Mar 14;14(3):e0213825 [PMID: 30870526]
  15. Vaccines (Basel). 2023 Mar 09;11(3): [PMID: 36992202]
  16. Hum Vaccin Immunother. 2023 Dec 31;19(1):2162301 [PMID: 36715009]
  17. Ann Epidemiol. 1992 Nov;2(6):805-12 [PMID: 1342333]
  18. Infect Disord Drug Targets. 2014;14(2):133-9 [PMID: 25019234]
  19. Vaccine X. 2023 Jun 05;14:100327 [PMID: 37333054]
  20. Vaccines (Basel). 2023 Dec 08;11(12): [PMID: 38140235]
  21. Rev Med Liege. 2023 Nov;78(11):665-673 [PMID: 37955298]
  22. Vaccines (Basel). 2024 Mar 17;12(3): [PMID: 38543951]

MeSH Term

Humans
Pilot Projects
Aged
Italy
Male
Female
Frail Elderly
Aged, 80 and over
Influenza Vaccines
Pneumococcal Vaccines
Vaccination
Outpatients
Influenza, Human
Immunization Programs

Chemicals

Influenza Vaccines
Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinationinfluenzaolderfrailpeoplestudyamongpneumococcaloutpatientspatientsVaccinationparticularlypneumococcuspilotstrategyaffectedcognitiveendocrinologicalItaly76previouslow-costprimarypreventionusefulavoidhardcomplicationsaimedassesseffectmainlyconditionsevaluatingstimulatedemotivateconducted2023-2024seasonoutpatientclinicsPalermototalincludedhalfconsideredpre-frail20%accordingcomprehensivegeriatricevaluationAmong4605%received2895%vaccinations250%Comparedseasons195%increase902%vaccineuptakeobservedSideeffectsmainreasonrejectionnamely9%538%anti-pneumococcalconclusionindicatesnewdifferentsettingsfeasibleProposingeffectiveinstrumentimproveimmunizationcoveragestilllowManagementcampaignpopulationconditions:Anti-pneumococcusFrailtyInfluenzaOlder

Similar Articles

Cited By (1)